Metraipolis › archive › dc_a1b2eaba41aa

PARP inhibitor maintenance treatment for newly diagnosed ovarian cancer patients: a real-world study from China — Europe PMC PMID:38371630

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/38371630
DOI: 10.3389/fonc.2024.1336616
License (as archived): solo-consultazione
Archived: 2026-10-10T00:52:38.935Z
SHA-256 of the archived text: 60555dbdb7ddc8eeb9f22250a939af367f985db472e6b8a5f62d6224cc15f3db
Stable URL of this page: https://metraipolis.com/documento/dc_a1b2eaba41aa

How to cite

PARP inhibitor maintenance treatment for newly diagnosed ovarian cancer patients: a real-world study from China — Europe PMC PMID:38371630 — Europe PMC (en), https://europepmc.org/article/MED/38371630 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a1b2eaba41aa (Metraipolis archive dc_a1b2eaba41aa, sha256 60555dbdb7ddc8eeb9f22250a939af367f985db472e6b8a5f62d6224cc15f3db)

BibTeX

@misc{dca1b2eaba41aa,
  title = {PARP inhibitor maintenance treatment for newly diagnosed ovarian cancer patients: a real-world study from China — Europe PMC PMID:38371630},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38371630},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a1b2eaba41aa; sha256 60555dbdb7ddc8eeb9f22250a939af367f985db472e6b8a5f62d6224cc15f3db},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/38371630. Agents can read the archived copy with the MCP tool read_document.